A new stem cell-based test may add certainty to efforts to predict whether so-called variants of uncertain significance will contribute to the development of diseases or be harmless. 

To conquer STEMI’s “last frontier,” cardiologists are tapping into an evolving arsenal of strategies while calling for more data and standardized definitions to guide treating physicians.

Even though the Hospital Readmission Reduction Program (HRRP) targeted principal heart failure admissions, a new analysis in the Journal of the American College of Cardiology showed readmissions also declined for patients with a secondary diagnosis of heart failure.

Tracking patients’ changes in fractional flow reserve (FFR) from before to after a percutaneous coronary intervention (PCI) may provide useful information, according to new research published in JAMA Cardiology. Individuals with the greatest change in FFR were less likely to experience vessel-related events and demonstrated greater symptomatic relief.

By the time three transplant physicians approached Tom Giangiulio Jr. about being the first patient in a new clinical trial to accept a heart from a Hepatitis C-positive donor, Giangiulio didn’t have much of a choice.

Patients who remain in the hospital for longer than three days following transcatheter aortic valve replacement (TAVR) are at a 45 percent increased risk of death within one year versus those discharged sooner after the procedure, a new analysis found.

The Early Bird Bleed Monitoring System, which can detect internal bleeding during endovascular procedures, has been granted de novo classification by the FDA. The approval was announced March 5 by Saranas, the device’s manufacturer.

Following the news that FDA Commissioner Scott Gottlieb, MD, plans to resign in about a month, the American Heart Association released a statement applauding Gottlieb’s efforts to curb the e-cigarette epidemic among the country’s youth.

In its first scientific statement on accurately measuring blood pressure in 14 years, the American Heart Association gave a stronger recommendation for oscillometric devices and updated the evidence surrounding ambulatory and home blood pressure monitoring techniques.

FDA Commissioner Scott Gottlieb is resigning. Gottlieb has manned the agency since May 2017 and will leave his position in about a month.

Drug manufacturer Eli Lilly plans to offer a half-priced version of its insulin medication Humalog, the company announced March 4.

The Apple Watch’s FDA-cleared electrocardiogram (ECG) feature has already helped some people uncover undiagnosed atrial fibrillation, leading to necessary medical treatment. But cardiologists fear false positives may be the more common occurrence in low-risk individuals, potentially leading to unnecessary testing and emotional strain in those users, according to Politico.